Last10K.com

Astrazeneca Plc (AZN) SEC Filing 6-K Foreign Issuer report for the period ending Wednesday, May 6, 2020

Astrazeneca Plc

CIK: 901832 Ticker: AZN

View differences made from one to another to evaluate Astrazeneca Plc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Astrazeneca Plc.

Continue

Assess how Astrazeneca Plc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Astrazeneca Plc's Definitive Proxy Statement (Form DEF 14A) filed after their 2020 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: AZN
CIK: 901832
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001654954-20-004956
Submitted to the SEC: Wed May 06 2020 7:33:41 AM EST
Accepted by the SEC: Wed May 06 2020
Period: Wednesday, May 6, 2020
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/azn/0001654954-20-004956.htm